BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking

被引：38
作者：
Chen F. [1 ]
Zhang G. [1 ]
Iwamoto Y. [1 ,2 ]
See W.A. [1 ]
机构：
[1] Department of Urology, Medical College of Wisconsin, Milwaukee, WI
[2] Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, WI
来源：
BMC Urology | / 5卷 / 1期
关键词：
Urothelial Cell; 253J Cell; Bacille Calmette Guerin; Urothelial Carcinoma Cell; Respective Cell Line;
D O I：
10.1186/1471-2490-5-8
中图分类号：
学科分类号：
摘要：
Background: Current models of the mechanism by which intravesical BCG induces an anti-tumor effect in urothelial carcinoma propose a secondary cellular immune response as principally responsible. Our group has demonstrated that BCG mediated cross-linking of α5 β 1 integrin receptors present on the tumor surface elicits a complex biologic response involving AP1 and NF-κB signaling as well as the transactivation of immediate early genes. This study evaluated the direct biologic effect of cross-linking α5β1 integrin on cell cycle progression and apoptosis in two human urothelial carcinoma cell lines. Methods: Two independent assays (MTT and Colony forming ability) were employed to measure the effect of α5β1 cross-linking (antibody mediated or BCG) on cellular proliferation. Flow cytometry was employed to measure effect of BCG and α5β1 antibody mediated cross-linking on cell cycle progression. Apoptosis was measured using assays for both DNA laddering and Caspase 3 activation. Results: Results demonstrate that integrin cross-linking by BCG, or antibody mediated crosslinking of α5β1 resulted in a decrease in proliferating cell number. BCG treatment or α5β1 cross-linking increased the percentage of cells in G0/G1, in both 253J and T24 cell lines. Peptide mediated blockade of integrin binding site using RGDS reversed the effect BCG on both proliferation and cell cycle arrest. Apoptosis in response to BCG was not identified by either DNA laddering or Caspase 3 activation. Conclusion: These findings show that BCG exerts a direct cytostatic effect on human urothelial carcinoma cell lines. Cell cycle arrest at the G1/S interface is a mechanism by which BCG inhibits cellular proliferation. This effect is duplicated by antibody mediated cross-linking of α5β1 and likely occurs as a consequence of crosslink-initiated signal transduction to cell cycle regulatory genes. © 2005 Chen et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 18 条
[1]  
Malkowicz S.B., Intravesical therapy for superficial bladder cancer, Semin Urol Oncol, 18, 4, pp. 280-288, (2000)
[2]  
Bohle A., Jocham D., Bock P.R., Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: A formal meta-analysis of comparative studies on recurrence and toxicity, J Urol, 169, 1, pp. 90-95, (2003)
[3]  
Sylvester R.J., Van Der Meijden A.P., Lamm D.L., Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: A meta-analysis of the published results of randomized clinical trials, J Urol, 168, 5, pp. 1964-1970, (2002)
[4]  
Bohle A., Brandau S., Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer, J Urol, 170, 3, pp. 964-969, (2003)
[5]  
Pryor K., Stricker P., Russell P., Et al., Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha 2b on human bladder cancer cells in vitro, Cancer Immunol Immunother, 41, 5, pp. 309-316, (1995)
[6]  
Seow S.W., Rahmat J.N., Mohamed A.A., Et al., Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin), J Urol, 168, 5, pp. 2236-2239, (2002)
[7]  
Liu B.C., Redwood S.M., Weiss R.E., Et al., Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction, J Urol, 148, 3, pp. 900-905, (1992)
[8]  
Chen F., Zhang G., Iwamoto Y., See W.A., Bacillus Calmette-Guerin initiates intracellular signaling in a transitional carcinoma cell line by cross-linking α5β1 integrin, J Urol, 170, 2 PART 1, pp. 605-610, (2003)
[9]  
Chen F.-H., Crist S.A., Zhang G.-J., Interleukin-6 production by human bladder tumor cell lines is upregulated by BCG through NF-κb and AP-1 via an immediate early pathway, J Urol, 168, pp. 786-797, (2002)
[10]  
Mosmann T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays, J Immunol Methods, 65, pp. 55-63, (1983)
12